{"query": "Stocks to watch today: Reliance Power, Cipla, Shriram Finance, IT stocks", "similar": [{"title": "Bharti Airtel, RIL, Vodafone idea, SBI, ZEEL, Srei Infra Finance, Cadila Healthcare stocks in focus", "date": "2021-10-06 08:49:18.000", "impact": "-6.99%"}, {"title": "Key Stocks Under Focus: Oil Companies, Wipro, Tata Power, Max Healthcare & More", "date": "2022-08-19 05:30:00.000", "impact": "+0.29%"}, {"title": "Reliance Industries: Is it a Stock In Peril", "date": "2023-02-13 14:39:00.000", "impact": "-0.99%"}]}
{"query": "Stocks to watch: Cipla, Greaves Cotton, PC Jeweller, Shriram Finance", "similar": [{"title": "Britannia among top 4 stock picks by experts as we enter 2023", "date": "2022-12-29 08:10:24.000", "impact": "-4.53%"}, {"title": "Key Stocks in Focus on Dec 8: Infosys, Eicher, BLS International, Lumax & More", "date": "2022-12-08 05:30:00.000", "impact": "-0.58%"}, {"title": "HCL Tech, Navin Fluorine, Bata India And More: Axis Securities’ Top Picks For January", "date": "2022-01-05 07:46:32.000", "impact": "-3.41%"}]}
{"query": "Cipla gets CDSCO nod to launch inhalation insulin", "similar": [{"title": "This device diagnoses multiple diseases within 15 minutes", "date": "2023-01-18 11:11:25.000", "impact": "-1.59%"}, {"title": "Cipla vows to crack diabetes segment with licensed branded portfolio", "date": "2023-05-25 15:00:00.000", "impact": "+3.83%"}, {"title": "Cipla and subsidiary secure USFDA nod on Lanreotide Injection", "date": "2021-12-20 08:59:00.000", "impact": "+5.13%"}]}
{"query": "Cipla gets approval to market Afrezza insulin inhalation powder in India", "similar": [{"title": "Roche’s antibody cocktail launched in India at ₹59,750/dose", "date": "2021-05-24 12:11:50.000", "impact": "+0.36%"}, {"title": "Cipla’s Promising Growth Prospects in India and the US", "date": "2023-05-06 20:56:14.000", "impact": "+1.58%"}, {"title": "U.S. FDA Flags Operational, Procedural Lapses At Cipla’s Goa Unit", "date": "2022-09-20 11:12:30.000", "impact": "+2.31%"}]}
